Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.
about
Strategies to minimize readmission rates following major urologic surgeryContemporary retroperitoneal lymph node dissection (RPLND) for testis cancer in the UK - a national study.A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer.
P2860
Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Characterizing the Morbidity o ...... of Privately Insured Patients.
@en
type
label
Characterizing the Morbidity o ...... of Privately Insured Patients.
@en
prefLabel
Characterizing the Morbidity o ...... of Privately Insured Patients.
@en
P2093
P2860
P1433
P1476
Characterizing the Morbidity o ...... of Privately Insured Patients.
@en
P2093
Atreya Dash
Brodie A Parent
Daniel W Lin
George R Schade
Jasmir G Nayak
John L Gore
Jorge D Ramos
Saneal Rajanahally
Sarah K Holt
P2860
P356
10.1016/J.UROLOGY.2016.01.010
P407
P577
2016-01-20T00:00:00Z